₹2,393.70
+₹28.70 (+1.21%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹97,756 Cr
P/E
47.28
ROE
11.74%
ROCE
13.13%
About Mankind Pharma Ltd
Mankind Pharma is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. Pursuant to scheme of amalgamation, the Company has three manufacturing facilities at Paonta Sahib in the state of Himachal Pradesh, one manufacturing facility in state of Sikkim, two manufacturing facilities in state of Rajasthan, one manufacturing facility in state of Andhra Pradesh, three in-house research and development centres in the state of Haryana and one research and development centre in the state of Maharashtra to carry out research in pharmaceutical products.
Founded
1991
CEO
RAMESH CHAND JUNEJA
Employees
21,325
HQ
New Delhi, India
About Mankind Pharma Ltd
Mankind Pharma is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. Pursuant to scheme of amalgamation, the Company has three manufacturing facilities at Paonta Sahib in the state of Himachal Pradesh, one manufacturing facility in state of Sikkim, two manufacturing facilities in state of Rajasthan, one manufacturing facility in state of Andhra Pradesh, three in-house research and development centres in the state of Haryana and one research and development centre in the state of Maharashtra to carry out research in pharmaceutical products.
Founded:1991
CEO:RAMESH CHAND JUNEJA
Employees:21,325
HQ:New Delhi, India
Finished Products
1Pharmaceuticals/Health care Pr
₹28,381.61Cr2Sale of Services
₹174.57Cr3Other Operating Revenues
₹1.66CrRaw Materials
1Pharmaceuticals/Health Care
₹3,545.84Cr2Purchase of Stock in Trade
₹1,825.86Cr3Cost of Material Consumed
₹1,594.05Cr4Raw Material Consumed
₹860.52CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,674
52W Low
₹1,910
Volume513.00K
Avg VolumeN/A
Beta0.72
Dividend Yield0.04%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
47.28x
Valuation
P/B Ratio
6.00x
Valuation
EPS
₹50.06
Valuation
Dividend Yield
0.04%
Valuation
ROE
11.74%
Profitability
ROCE
13.13%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and trading of pharmaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
85.6%
International
14.4%
Within India85.6%
Outside India14.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.39x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
11.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.